Group 1 - The core viewpoint of the report indicates that the Hong Kong market liquidity index has slightly decreased, supported by improved southbound capital inflows and increased stock yields, while being hindered by the widening SOFR-HIBOR spread, a stronger US dollar index, and heightened market volatility [1][2] - In February, Hong Kong's foreign exchange reserves increased by 3.6 billion USD, reaching 439.2 billion USD, and the monetary base rose by 12.9 billion HKD to 2.07 trillion HKD [1] - The net capital inflow for January was 72 billion HKD, marking the third consecutive month of net inflows, although southbound net inflows decreased from 110.1 billion HKD to 49.8 billion HKD [1][2] Group 2 - The MSCI Emerging Markets Currency Index fell by 1.5%, and the MSCI Emerging Markets Index decreased by 5.0%, while the iShares MSCI Hong Kong ETF experienced net outflows [2] - The average daily trading volume remained stable at approximately 283.1 billion HKD, reflecting a month-on-month increase of 7.7% but a year-on-year decline of 13.6% [2] - The M3 money supply grew by 9.8% in January, continuing a trend of over 9% growth for thirteen consecutive months, while loans increased for the ninth consecutive month, with a year-on-year growth of 3.7% [2] Group 3 - The report notes that the recent escalation of the Middle East situation has heightened concerns about imported inflation and slowing growth, leading to a rapid decline in global risk appetite and increased volatility in the Hong Kong market [3] - The Federal Reserve's guidance indicates a potential for at least one rate cut this year, despite a tightening structure in the dot plot, reflecting a shift towards a "higher for longer" policy stance [3][4] - The report suggests that the market's reaction to stagflation risks and hawkish Fed pricing may be overdone, with a high threshold for rate hikes, and emphasizes the importance of monitoring geopolitical developments and oil price transmission in the coming month [4]

Investment Rating - The report assigns an "Outperform" rating to Novo Nordisk with a target price of $43.29 [6][12]. Core Insights - Novo Nordisk is at a unique historical juncture, experiencing a stock price correction in 2025, which has led to valuation compression. The market is overlooking the company's solid market share in diabetes and its long-term dominance in the obesity market. Short-term catalysts include performance rebounds from capacity releases, while mid-term drivers are the confirmatory data for CagriSema and oral new drugs. Long-term growth is expected from Amycretin and new indications, creating an attractive entry point for investors [1]. - The valuation logic for 2026 anticipates a decline in adjusted sales and operating profit by approximately 6% and 9%, respectively. A 13x P/E for 2026 reflects the market's early pricing of a rebound in 2027, considering the company's premium as a GLP-1 leader and expectations of negative news being priced in [2]. - The recovery path for 2027-2028 is supported by cost savings from restructuring, ramp-up of new factory capacity, and dual drivers from oral semaglutide and CagriSema, with adjusted profit growth expected to rebound to around 17% [3]. Financial Projections - Revenue (in million DKK) is projected to be 290,403 in 2024, 309,064 in 2025, 291,589 in 2026, 331,054 in 2027, and 359,755 in 2028, with year-on-year growth rates of 25%, 6%, -6%, 14%, and 9% respectively [4]. - Net profit (in million DKK) is expected to be 100,988 in 2024, 102,434 in 2025, 97,351 in 2026, 116,733 in 2027, and 136,190 in 2028, with year-on-year growth rates of 21%, 1%, -5%, 20%, and 17% respectively [4]. - The diluted earnings per share (in DKK) are forecasted to be 22.63 in 2024, 23.03 in 2025, 22.11 in 2026, 26.51 in 2027, and 31.07 in 2028, with year-on-year growth rates of 22%, 2%, -4%, 20%, and 17% respectively [4]. Valuation and Market Context - The report highlights that Novo Nordisk's current market valuation is significantly lower than the industry average due to negative growth guidance for 2026, with a forward adjusted P/E of approximately 11.5x-13.0x [11]. - The report anticipates a re-rating of Novo Nordisk's valuation towards the industry average of 15x+, driven by expected double-digit revenue growth in 2027 [11]. - The global market for GLP-1 drugs is projected to grow significantly, with penetration rates currently low, indicating substantial growth potential [18][33].

Investment Rating - The report assigns an "Outperform" rating to Novo Nordisk with a target price of $43.29 [6][12]. Core Insights - Novo Nordisk is at a unique historical juncture with a stock price correction expected in 2025, leading to valuation compression. The market is overlooking the company's solid position in the diabetes sector and its long-term dominance in the global obesity market. Short-term catalysts include performance rebounds from capacity releases, mid-term confirmation data for CagriSema and oral new drugs, and long-term revenue growth opportunities from Amycretin and new indications [1]. - The valuation logic for 2026 anticipates a decline in adjusted sales and operating profit by approximately 6% and 9%, respectively. The expected P/E ratio of 13 reflects the market's pricing of a rebound in 2027 through the fog of short-term negative growth. A resolution of the 340B issue and completion of restructuring could lead to better-than-expected performance [2]. - The recovery path for 2027-2028 is supported by cost savings from restructuring, ramp-up of new factory capacity, and dual drivers from oral semaglutide and CagriSema, with adjusted profit growth expected to rebound to around 17%. The anticipated double-digit growth in net profit from 2027 to 2028 will allow the P/E ratio to recover from 13.0x in 2026 to 14.5x in 2027 [3]. Financial Projections - Revenue (in million DKK) is projected to be 290,403 in 2024, 309,064 in 2025, 291,589 in 2026, 331,054 in 2027, and 359,755 in 2028, with year-on-year growth rates of 25%, 6%, -6%, 14%, and 9%, respectively [4]. - Net profit (in million DKK) is expected to be 100,988 in 2024, 102,434 in 2025, 97,351 in 2026, 116,733 in 2027, and 136,190 in 2028, with year-on-year growth rates of 21%, 1%, -5%, 20%, and 17%, respectively [4]. - The diluted earnings per share (in DKK) are forecasted to be 22.63 in 2024, 23.03 in 2025, 22.11 in 2026, 26.51 in 2027, and 31.07 in 2028, with year-on-year growth rates of 22%, 2%, -4%, 20%, and 17%, respectively [4]. Market Context - The global obesity and diabetes crisis is escalating, with obesity and diabetes being major drivers of cardiovascular diseases, chronic kidney disease, and other metabolic disorders. The current global penetration rate of GLP-1 drugs is still below 8% in the US and 1% in China, indicating significant growth potential [18]. - The number of diabetes patients globally is projected to rise from 589 million in 2024 to 853 million by 2050, with a significant increase in obesity rates as well. This dual epidemic presents a substantial market opportunity for GLP-1 receptor agonists [22][24].

Investment Rating - The report assigns an "Outperform" rating to the covered companies in the high-end manufacturing sector, indicating an expected return above 10% over the next 12 months [5][6]. Core Insights - The high-end manufacturing sector is expected to see a profit recovery in Q4 2025, driven by a significant rebound in downstream demand within the industrial automation segment. Companies like Inovance Technology, Estun Automation, and Harmonic Drive are projected to achieve revenue growth between 21% and 47%, with net profit growth ranging from 21% to 122% [1]. - The 2026 theme focuses on physical AI, overseas expansion, and high-growth sub-sectors, with attractive opportunities identified in the intersection of physical AI, robotics, domestic substitution, and overseas expansion [3]. Summary by Sections Q4 2025 Performance - The overall industry shows a converging trend in performance, with leading companies like Sanhua and Inovance experiencing a slowdown in quarterly growth, while previously weaker firms like Topband and Shuanghuan Transmission are beginning to show signs of revenue and profit recovery [2]. - Profitability pressures are evident, with the overall net profit margin in 2025 expected to be lower than in 2024 due to intensified price competition in the electric vehicle and industrial automation markets, rising commodity prices (copper +30%, aluminum +20%), and chip supply shortages [2]. 2026 Investment Themes - The investment logic for 2026 revolves around three main directions: redefining industrial automation as the infrastructure for physical AI, empowering industrial processes with Agentic AI, and the trend of global manufacturing returning [3]. - The HALO investment strategy emphasizes high replacement costs, large physical infrastructure, and customer stickiness, which provide strong pricing power. This strategy is gaining traction as valuations of industrial stocks in Japan and South Korea are being reassessed [3]. Valuation Metrics - The report provides valuation metrics for various companies, with target prices and expected growth rates. For instance, Sanhua H is rated with a target price of HKD 49.00 and a projected PE of 25.3, while Inovance is rated with a target price of HKD 98.00 and a projected PE of 30.7 [5].

Investment Rating - The report assigns an "Outperform" rating for the industry, indicating an expected return above 10% over the next 12 months [7]. Core Insights - The consumption data during the Spring Festival exceeded expectations, validating the effectiveness of recent policies aimed at stabilizing consumption and highlighting the recovery of service-oriented and experiential consumption compared to traditional retail [5]. - The report anticipates that the decision-makers will continue the positive momentum established during the Spring Festival, with further targeted and gradual easing measures expected around the "Two Sessions" to stabilize expectations and support demand [5]. - Leading restaurant operators with significant scale advantages and strong cost control capabilities, as well as core duty-free operators benefiting from long-term policy advantages, are expected to achieve relative gains as the consumption cycle normalizes [5]. Summary by Sections Spring Festival Consumption - The Spring Festival consumption was better than expected, with key retail and catering enterprises showing a year-on-year sales growth of 5.7%, significantly higher than the previous year's growth rates of 4.1% and 2.7% during the Mid-Autumn Festival [1]. - Over 20.5 billion yuan in consumption vouchers and subsidies were issued by local governments, effectively supporting demand [1]. Restaurant Sector - Increased dining demand was driven by higher travel frequency, milder weather, and longer holidays, with New Year's Eve dining reservations increasing over threefold year-on-year [2]. - Major dining brands and supermarkets launched diverse ready-to-eat and semi-finished meal boxes, catering to family gatherings and reflecting a shift in consumer preferences towards convenience [2]. Tourism Sector - The extended holiday boosted tourism demand, with significant year-on-year increases in customer flow and orders for themed tourism such as ice and snow tours [3]. - Domestic travel orders reached new highs, with ticket bookings for scenic spots increasing by over 80% and hotel night stays rising by 75% [3]. Duty-Free Consumption - Duty-free sales in Hainan saw a substantial year-on-year increase of 30.8% to 2.72 billion yuan during the Spring Festival, driven by improved supply and operational efficiency following the implementation of new policies [4]. - The strong performance of duty-free consumption underscores the resilience and profitability potential of domestic duty-free channels [4].

Investment Rating - The report maintains an "Outperform" rating for several companies in the high-end manufacturing sector, particularly those involved in robotics [5]. Core Insights - The market is currently experiencing a strong upward trend driven by positive news flow, particularly in the robotics sector, with the Wind Robotics Index rising by 18.2% in September [1]. - There is a notable divergence between current valuations and financial conditions, suggesting that while the market remains optimistic, the potential for correction exists as the sector approaches previous highs [2][3]. - The report emphasizes the cyclical nature of the robotics theme, indicating that short-term trading strategies should include profit-taking rather than simple holding [3]. Summary by Sections Market Performance - The robotics theme stocks have shown strong performance, with significant gains in various companies, such as Hanwei Technology up 27.5% and Wolong Electric up 39.8% [1]. - The report notes that many high-end manufacturers have not yet surpassed their March peaks, indicating potential for further gains [2]. Financial Analysis - The financial conditions of robotics manufacturers have shown resilience, with actual order acquisition and technological advancements driving recent market increases [2]. - The report highlights that the current market valuation may not be sustainable without further financial improvements, as the sector is experiencing high premiums [2][3]. Long-term Outlook - The long-term prospects for the robotics industry remain positive, driven by strong policy support, talent influx, and significant R&D investments [3]. - The report suggests that the emergence of fully autonomous humanoid robots and a new robotics industry could occur in the future, although current applications are limited to industrial and logistics sectors [3].

Investment Rating - The report maintains an "Outperform" rating for several key companies in the robotics sector, indicating an expected return above 10% over the next 12 months [7]. Core Insights - The World Artificial Intelligence Conference showcased over 3,000 cutting-edge exhibits, highlighting advancements in humanoid robots capable of performing human-like tasks [1]. - Companies like Zhiyuan and Yushu Technology are focusing on commercializing their robotic products, with plans for regular updates and a strong emphasis on understanding customer needs [1][2]. - The report identifies upcoming events, such as the World Robot Conference and the Optimus Gen 3 launch, as catalysts for further interest and investment in the robotics sector [4][6]. Summary by Sections High-end Manufacturing - The World Artificial Intelligence Conference featured over 800 companies and emphasized the increasing capabilities of robots in executing human-like behaviors [1]. - Zhiyuan's strategy includes regular updates to their robot models and a focus on aligning technology with customer applications [1]. - Yushu Technology introduced its third-generation humanoid robot, R1, targeting AI developers and educational institutions, showcasing its competitive edge in robotic movement [2]. Company Dynamics - Fourier and InTime Robotics presented new products aimed at enhancing human-robot interaction and multi-modal perception capabilities [3]. - Midea Group is advancing its "home appliance robot" initiative, integrating robotics into its product lines, with plans for market entry by 2025 [3]. Market Outlook - The report highlights the anticipated production of Tesla's Optimus Gen 3, with a target of over 1 million units by 2030, indicating strong market potential for humanoid robots [4]. - Increased orders in the robotics supply chain are expected to provide updates in mid-August, further supporting the positive outlook for the sector [4]. - Preferred investment targets include companies specializing in gears, actuators, and overall robotics manufacturing, with a cautionary note on potential profit-taking pressures in the short term [4]. Valuation Table - The report includes a valuation table for key Chinese robotics companies, indicating expected price targets and growth rates for 2025, with several companies rated as "Outperform" [5].

Global Market Strategy - The core viewpoint of the report indicates that the U.S. is implementing a "reciprocal tariff" mechanism, with tariffs ranging from 10% to 50% on various countries' goods, leading to significant market volatility and adjustments in policy timelines [1][2][3] - The U.S. has postponed the implementation of these tariffs from July 9 to August 1, allowing for further negotiations with multiple countries [1][2] U.S.-Japan Agreement - The U.S. and Japan have reached a "reciprocal tariff" agreement, reducing tariffs to 15% in exchange for a commitment of $550 billion in investments from Japan [2][4] - This agreement marks a significant bilateral trade model, suggesting that similar concessions may be required from other countries to receive the same tariff rate [2][4] U.S.-EU Negotiations - U.S.-EU negotiations are in advanced stages, with a potential 30% tariff threat still looming [3][5] - The U.S. has sent letters to the EU, indicating a push for a 15% baseline tariff, while the EU's automotive sector faces significant pressure due to its dual role as both a major importer and exporter of vehicles to the U.S. [5][15] Tariff Structure - The report outlines a tiered tariff structure based on trade relationships, with three main levels: 1. Countries with trade deficits and small allies (approx. 10% tariff) 2. Surplus countries with strategic value (initial tariff range of 15%-35%) 3. Low-income surplus countries with high-risk of transshipment (initial tariff range of 35%-40%) [8][11][13] - The EU is identified as facing unique challenges due to its complex trade relationship with the U.S., particularly in the automotive and steel sectors [15][27] China and Other Special Cases - China remains a focal point in the tariff discussions, with ongoing negotiations centered around non-tariff barriers and a 90-day freeze on new tariffs until August 12 [21][26] - Other countries like Mexico and Canada are under pressure due to their integration in the USMCA framework, with potential tariffs of 30% and 35% respectively if agreements are not reached by the deadline [29][28] Market Reactions - The market's response to the tariff announcements has been less severe than anticipated, with investors having already priced in extreme scenarios [32][41] - The report suggests that the market is adapting to a pattern of negotiation where initial threats are followed by adjustments, leading to a more stable outlook for key economies [36][39]

Core Insights - The Hong Kong market liquidity index has rebounded to positive values after turning negative last month, supported by factors such as the narrowing SOFR-HIBOR spread, decreased volatility, and increased southbound capital flow [1] - In June, Hong Kong's foreign exchange reserves increased by USD 800 million to USD 431.9 billion, while the monetary base decreased by HKD 4.7 billion to HKD 2.12 trillion [1] - Capital inflows have returned to positive territory, with net inflows into Hong Kong stocks reaching HKD 231 billion in May, and southbound net inflows increasing from HKD 83.2 billion to HKD 92.8 billion [2] Market Performance - The Hong Kong market has continued a moderate upward trend, breaking through significant levels of 24,000 and 25,000 points, driven by improved US-China relations and better-than-expected economic data from China [4] - The average daily trading volume has expanded, reaching approximately HKD 239.1 billion, an increase of 8.4% month-on-month and 136.1% year-on-year [2] Monetary Supply and Loan Data - Total deposits in May grew by 10.7% year-on-year, with M3 growth also at 10.7%, marking the fifth consecutive month above 9% [3] - Loan growth turned positive for the first time since May 2022, with a year-on-year increase of 1.0% [3] Economic Indicators - The MSCI Emerging Markets Currency Index rose by 0.2%, while the MSCI Emerging Markets Index increased by 3.6% [2] - The iShares MSCI Hong Kong ETF recorded net inflows over the past month, although the Hang Seng Index underperformed compared to the emerging markets index, rising only 2.2% [2]

Investment Rating - The report maintains an "Outperform" rating for Pop Mart (09992) and raises the target price from HKD 256 to HKD 288, an increase of 12.5% [1] Core Insights - Pop Mart is expected to sustain growth with upcoming product launches and is rapidly increasing production to meet rising demand [1] - The company has strong intellectual property enforcement capabilities, which supports its valuation based on a 47% compound annual growth rate in earnings [1] - With robust operational and commercialization capabilities, smooth overseas expansion, and a comprehensive distribution network, Pop Mart remains a preferred choice in the industry [1]